StocksN › NYCB

New York Community Bancorp, Inc. (NYCB) — Earnings Call X-Ray

Our AI read all 35 of NYCB's earnings calls (2016–2024) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q3 2024 · sign up to see
Previous Call Grade
C
Q2 2024
Expected Move
🔒
next 45 days · members
Calls Analyzed
35
2016–2024
Avg Candor
6.5/9
evasion 3.6/9
Guidance LoweredHigh CandorSkeptic ReassuredCritic AmmunitionRaising PricesMargins ContractingQuestion Left HangingResults Worse Than Direction

Call-by-call analysis

🔒 Q3 2024 earnings call 2024-10-25 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q3 2024 call grade is ready
The full 37-point AI read of NYCB's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

C Q2 2024 earnings call 2024-07-25 move ±16.1%

Management lowered guidance against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: mixedMargins: contractingPricing: raisingHeadcount: growing 10 analysts · 31 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Resolves doubtsDirection beats results
Candor 8/9
Specificity 8/9
Evasion 2/9
Confidence 7/9
Uncertainty 4/9
Promotion 6/9
Stress 3/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C Q1 2024 earnings call 2024-05-01 move ±16.6%

Management held guidance steady against steady demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: stableMargins: contractingPricing: under pressureHeadcount: cutting 15 analysts · 38 questions
⚑ Critic ammunition⚑ Question left hanging✓ Resolves doubtsDirection beats results
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 7/9
Uncertainty 5/9
Promotion 6/9
Stress 4/9
Complexity 6/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

F Q4 2023 earnings call 2024-01-31 move ±27.1%

Management lowered guidance against slowing demand and contracting margins. The delivery was rich in specifics, frequently evasive, visibly under pressure.

Guidance: loweredDemand: slowingMargins: contractingPricing: under pressure 13 analysts · 30 questions
⚑ Critic ammunition⚑ Question left hangingDirection beats results
Candor 6/9
Specificity 7/9
Evasion 6/9
Confidence 4/9
Uncertainty 6/9
Promotion 5/9
Stress 8/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

D Q3 2023 earnings call 2023-10-26 move ±12.7%

Management lowered guidance against steady demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: stableMargins: expandingPricing: raisingHeadcount: growing 14 analysts · 27 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 8/9
Uncertainty 4/9
Promotion 6/9
Stress 3/9
Complexity 6/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q2 2023 earnings call 2023-07-27 move ±11.1%

Management held guidance steady against steady demand and expanding margins. The delivery was rich in specifics, promotional in tone.

Guidance: maintainedDemand: stableMargins: expandingPricing: raisingHeadcount: growingCapex: increasing 10 analysts · 27 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts
Candor 6/9
Specificity 8/9
Evasion 2/9
Confidence 8/9
Uncertainty 3/9
Promotion 7/9
Stress 3/9
Complexity 7/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C Q1 2023 earnings call 2023-04-28 move ±11%

Management held guidance steady against steady demand and expanding margins. The delivery was rich in specifics.

Guidance: maintainedDemand: stableMargins: expandingPricing: raisingHeadcount: cutting 8 analysts · 23 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Resolves doubts
Candor 6/9
Specificity 7/9
Evasion 3/9
Confidence 7/9
Uncertainty 5/9
Promotion 6/9
Stress 3/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q4 2022 earnings call 2023-01-31 move ±8.4%

Management held guidance steady against slowing demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: slowingMargins: expandingBacklog: shrinkingPricing: raisingHeadcount: cuttingCapex: increasing 10 analysts · 30 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubtsDirection beats results
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 8/9
Uncertainty 3/9
Promotion 6/9
Stress 2/9
Complexity 6/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q3 2022 2022-10-26 D maintainedslowingcontracting 6/9 5/9
Q2 2022 2022-07-27 C+ maintainedacceleratingexpanding 6/9 3/9
Q1 2022 2022-04-27 D maintainedacceleratingstable 6/9 6/9
Q4 2021 2022-01-26 C maintainedacceleratingstable 6/9 5/9
Q3 2021 2021-10-27 C maintainedacceleratingexpanding 7/9 6/9
Q2 2021 2021-07-28 B+ raisedstableexpanding 7/9 3/9
Q4 2020 2021-01-27 C+ maintainedstableexpanding 7/9 3/9
Q3 2020 2020-10-28 B maintainedstableexpanding 7/9 2/9
Q2 2020 2020-07-29 C+ maintainedstableexpanding 7/9 3/9
Q1 2020 2020-04-29 C+ raisedacceleratingexpanding 6/9 3/9
Q4 2019 2020-01-29 C+ maintainedacceleratingexpanding 6/9 3/9
Q3 2019 2019-10-31 C maintainedmixedexpanding 6/9 3/9
Q2 2019 2019-07-31 B raisedstableexpanding 6/9 2/9
Q1 2019 2019-04-30 C+ maintainedmixedcontracting 6/9 3/9
Q4 2018 2019-01-30 D maintainedstablecontracting 6/9 4/9
Q3 2018 2018-10-24 D maintainedstablecontracting 6/9 4/9
Q2 2018 2018-07-25 C+ raisedacceleratingcontracting 6/9 4/9
Q1 2018 2018-04-25 D loweredstablecontracting 7/9 4/9
Q4 2017 2018-02-01 B maintainedacceleratingcontracting 7/9 2/9
Q3 2017 2017-10-25 F loweredacceleratingcontracting 7/9 6/9
Q2 2017 2017-07-26 D loweredacceleratingcontracting 6/9 4/9
Q1 2017 2017-04-26 D maintainedmixedcontracting 6/9 4/9
Q4 2016 2017-01-25 C maintainedmixedcontracting 7/9 4/9
Q3 2016 2016-10-26 C+ maintainedstablecontracting 7/9 4/9
Q2 2016 2016-07-27 C+ maintainedstablestable 6/9 3/9
Q1 2016 2016-04-20 C maintainedmixedstable 6/9 4/9
Q4 2015 2016-01-27 D maintainedstableexpanding 6/9 5/9

Research question bank — earlier calls

During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of NYCB's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.

C Q3 2021 earnings call 2021-10-27

1 more research questions answered NO

B Q4 2017 earnings call 2018-02-01

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAP · Advance Auto Parts, Inc.ABCAF · Athabasca Minerals, Inc.ABDC · Alcentra Capital'sABMD · Abiomed, Inc.ABNRY · ABN AMRO Bank N.V.ABOS · Acumen Pharmaceuticals,

NYC   All “N” companies    NYLD

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.